According to an SEC filing dated July 2, 2025, LVM Capital Management reduced its position in ICON Public Limited (ICLR 0.90%) by selling 16,096 shares. The transaction was valued at $2.58 million. After the trade, the fund holds 40,603 shares, with a reported market value of $5.91 million as of the June 2025 filing period.
This sell action lowers ICON Public Limited to 0.61% of LVM’s AUM, according to the 13F filing.
Top five ICON Public holdings after the filing:
Other need-to-know info about ICON Public:
Metric | Value |
---|---|
Current price | $147.59 |
Market capitalization | $11.73 billion |
Revenue (TTM) | $8.19 billion |
Net income (TTM) | $758 million |
Note: TTM figures are as of March 31, 2025.
ICON Public Limited is a leading global clinical research organization headquartered in Dublin, Ireland, with over 41,000 employees. The company leverages its scale and expertise to deliver end-to-end clinical development and commercialization services, supporting clients across all phases of drug and medical device development. Its integrated approach and broad service offering position ICON as a strategic partner to major healthcare innovators worldwide.
It's an interesting time for ICON Public, the company's stock has declined more than 54% in the last year as its top-line sales stagnate in the face of a shifting political landscape. The company, along with much of the industry, is facing headwinds from cuts to healthcare spending from the U.S. government, which represents a significant share of ICON’s revenue.
While these issues are real, I think the fear is overblown and the stock is oversold. ICON has proved itself to be deft at cutting costs to offset the struggling revenue generation; even as sales stagnated, the company grew its net earnings by 20% each quarter for the past year, save for the most recent quarter. Furthermore, there is a good chance that cutbacks in healthcare spending are temporary.
Finally, ICON has heavily invested in aiding its research with artificial intelligence (AI). I believe that it is exactly the kind of business that stands to gain significantly from its implementation. There may be more downside in the short term, but for investors with a long-term outlook, I think ICON remains a solid choice.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.